Spanish diagnostic solutions provider STAT-Dx is set to unveil its new in-vitro diagnostics system DiagCORE at the 27th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) being held in Vienna, Austria, between 22 and 25 April.

DiagCORE is a fully integrated multiplex real-time polymerase chain reaction (PCR) diagnosis platform with the potential to detect approximately 48 molecular targets simultaneously in a single sample.

Go deeper with GlobalData

Go deeper with GlobalData

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

The multiplex real-time PCR capability makes the system ideal for complex assays from all types of clinical samples.

STAT-Dx chief executive officer Jordi Carrera said: "We are delighted to be unveiling our DiagCORE system and first respiratory panel at ECCMID.

"STAT-Dx's fast, syndromic diagnostic system is set to become a key asset in the infectious diseases diagnostic market, which is rapidly embracing innovative multiplex PCR-based technologies.

"DiagCORE's simplicity and delivery of fast actionable answers has the potential to greatly improve clinical and economic outcomes. Furthermore, with low manufacturing costs at the core of our design, we are confident on being able to bring a highly competitive product to the market."

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData
"With low manufacturing costs at the core of our design, we are confident on being able to bring a highly competitive product to the market."

DiagCORE Respiratory Panel is the firm's first assay, with the capability to simultaneously detect and identify around 22 viral and bacterial pathogens.

The test can be used with nasopharyngeal swab samples from patients with acute respiratory symptoms.

STAT-Dx intends to commence registration trials for the respiratory panel, with plans to receive CE mark in the second half of this year.

The firm is also working on additional panels for clinical microbiology and infectious disease applications and expects to commercialise its second assay, Gastrointestinal Panel, next year.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
Awarded for Innovation in Remote Hearing Diagnostics , hearX’s Self Test Kit (STK) delivers clinically validated audiometry via smart devices, enabling remote, scalable hearing assessments in homes, clinics and retail. Learn how hearX is redefining hearing care delivery and reducing costs for providers globally.

Discover the Impact